{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:58:32Z","timestamp":1780588712206,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.nano.2015.07.010","type":"journal-article","created":{"date-parts":[[2015,8,15]],"date-time":"2015-08-15T12:45:25Z","timestamp":1439642725000},"page":"2041-2050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells"],"prefix":"10.1016","volume":"11","author":[{"given":"Anupma","family":"Dwivedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lissinda","family":"du Plessis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan L.","family":"du Preez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanetta","family":"du Plessis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.nano.2015.07.010_bb0005","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1200\/JCO.2000.18.22.3782","article-title":"Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials","volume":"18","author":"Manola","year":"2000","journal-title":"J Clin Oncol"},{"issue":"49","key":"10.1016\/j.nano.2015.07.010_bb0010","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1038\/sj.onc.1208890","article-title":"Caspase independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk\/Bik","volume":"24","author":"Oppermann","year":"2005","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.nano.2015.07.010_bb0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PPO.0b013e31824bc981","article-title":"Surgery for distant melanoma metastasis","volume":"18","author":"Leung","year":"2012","journal-title":"Cancer J"},{"issue":"12","key":"10.1016\/j.nano.2015.07.010_bb0020","first-page":"811","article-title":"Antimalaria studies on qinghaosu","volume":"92","author":"Antimalaria Coordinating Research Group","year":"1979","journal-title":"Chin Med J"},{"key":"10.1016\/j.nano.2015.07.010_bb0025","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): an antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.nano.2015.07.010_bb0030","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tips.2008.07.004","article-title":"Artemisinins: their growing importance in medicine","volume":"29","author":"Krishna","year":"2008","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.nano.2015.07.010_bb0035","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/np50096a007","article-title":"Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells","volume":"56","author":"Woerdenbag","year":"1993","journal-title":"J Nat Prod"},{"issue":"12","key":"10.1016\/j.nano.2015.07.010_bb0040","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1248\/bpb.25.1555","article-title":"Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562\/adr and GLC4\/adr resistant cell lines","volume":"25","author":"Reungpatthanaphong","year":"2002","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"10.1016\/j.nano.2015.07.010_bb0045","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/mol.64.2.382","article-title":"Molecular modes of action of artesunate in tumour cell lines","volume":"64","author":"Efferth","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.nano.2015.07.010_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/247597","article-title":"Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug","volume":"2012","author":"Crespo-Ortiz","year":"2012","journal-title":"J Biomed Biotechnol"},{"issue":"1","key":"10.1016\/j.nano.2015.07.010_bb0055","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","article-title":"Development of artemisinin compounds for cancer treatment","volume":"31","author":"Lai","year":"2013","journal-title":"Investig New Drugs"},{"issue":"4","key":"10.1016\/j.nano.2015.07.010_bb0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1871526513666131129155708","article-title":"Considerations on the mechanism of action of artemisinin antimalarials: part 1\u2014the 'carbon radical' and 'heme' hypotheses","volume":"13","author":"Haynes","year":"2013","journal-title":"Infect Disord Drug Targets"},{"key":"10.1016\/j.nano.2015.07.010_bb0065","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/cmdc.201200383","article-title":"Interactions between artemisinins and other antimalarial drugs in relation to the co-factor model\u2014a unifying proposal for drug action","volume":"7","author":"Haynes","year":"2012","journal-title":"ChemMedChem"},{"issue":"4","key":"10.1016\/j.nano.2015.07.010_bb0070","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0009-9236(98)90044-3","article-title":"Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria","volume":"63","author":"Ashton","year":"1998","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.nano.2015.07.010_bb0075","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/157488507781695649","article-title":"Pharmacokinetic and pharmacodynamic profiles of rapid-acting artemisinins in the antimalarial therapy","volume":"2","author":"Li","year":"2007","journal-title":"Curr Drug Ther"},{"key":"10.1016\/j.nano.2015.07.010_bb0080","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/jac\/dkl563","article-title":"Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo","volume":"59","author":"Vivas","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nano.2015.07.010_bb0085","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/anie.200690045","article-title":"Artemisone\u2014a highly active antimalarial drug of the artemisinin class","volume":"46","author":"Haynes","year":"2006","journal-title":"Angew Chem Int Ed"},{"issue":"3","key":"10.1016\/j.nano.2015.07.010_bb0090","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00280-010-1355-4","article-title":"In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents","volume":"67","author":"Gravett","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"10.1016\/j.nano.2015.07.010_bb0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000324053","article-title":"Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids","volume":"24","author":"Schlupp","year":"2011","journal-title":"Skin Pharmacol Physiol"},{"issue":"3","key":"10.1016\/j.nano.2015.07.010_bb0100","first-page":"2081","article-title":"Evaluation of transdermal targeted niosomal drug delivery of terbinafine hydrochloride","volume":"2","author":"Sathali","year":"2010","journal-title":"Int J Pharm Technol Res"},{"issue":"2","key":"10.1016\/j.nano.2015.07.010_bb0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1081\/DDC-100100348","article-title":"Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: encapsulation, storage, and in vitro release","volume":"26","author":"Ruckmani","year":"2000","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"10.1016\/j.nano.2015.07.010_bb0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.biopha.2014.01.004","article-title":"Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung","volume":"68","author":"Athawale","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nano.2015.07.010_bb0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijpharm.2014.03.036","article-title":"Pharmacokinetics study of arteether loaded solid lipid nanoparticles: an improved oral bioavailability in rats","volume":"466","author":"Dwivedi","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2015.07.010_bb0120","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.exppara.2012.04.010","article-title":"Curcuminoids-loaded liposomes in combination with arteether protects against Plasmodium berghei infection in mice","volume":"131","author":"Aditya","year":"2012","journal-title":"Exp Parasitol J"},{"issue":"4","key":"10.1016\/j.nano.2015.07.010_bb0125","first-page":"67","article-title":"Artemisinin (ART) drug deliveryusing mixed non-ionic surfactants and evaluation of their efficiency in different cancer cell lines","volume":"4","author":"Asgharkhani","year":"2014","journal-title":"Int J Drug Deliv Technol"},{"issue":"6","key":"10.1016\/j.nano.2015.07.010_bb0130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/10717544.2010.483252","article-title":"Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent","volume":"17","author":"Jain","year":"2010","journal-title":"Drug Deliv"},{"issue":"1\u20132","key":"10.1016\/j.nano.2015.07.010_bb0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijpharm.2011.05.003","article-title":"Absorption of the novel artemisinin derivatives artemisone and artemiside: potential application of Pheroid\u2122 technology","volume":"414","author":"Steyn","year":"2011","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.nano.2015.07.010_bb0140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1517\/17425255.2014.885503","article-title":"The effect of the Pheroid\u2122 delivery system on the in vitro metabolism and in vivo pharmacokinetics of artemisone","volume":"10","author":"Grobler","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1\u20132","key":"10.1016\/j.nano.2015.07.010_bb0145","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijpharm.2012.03.027","article-title":"Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies","volume":"430","author":"Wang","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2015.07.010_bb0150","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7150\/ijms.7.398","article-title":"Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer","volume":"7","author":"Yassin","year":"2010","journal-title":"Int J Med Sci"},{"issue":"36","key":"10.1016\/j.nano.2015.07.010_bb0155","first-page":"1","article-title":"In vitro anticancer evaluation of 5-fluorouracil lipid nanoparticles using B16F10 melanoma cell lines","volume":"3","author":"Shenoy","year":"2013","journal-title":"Int Nano Lett"},{"issue":"3","key":"10.1016\/j.nano.2015.07.010_bb0160","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1208\/s12249-010-9480-2","article-title":"Formulation and optimization of zidovudine niosomes","volume":"11","author":"Ruckmani","year":"2010","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.nano.2015.07.010_bb0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/2141-9248.153609","article-title":"Anticancer effect of antimalarial artemisinin compounds","volume":"5","author":"Das","year":"2015","journal-title":"Ann Med Health Sci Res"},{"key":"10.1016\/j.nano.2015.07.010_bb0170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1475-2875-9-227","article-title":"Artemisone effective against murine cerebral malaria","volume":"9","author":"Waknine-Grinberg","year":"2010","journal-title":"Malar J"},{"key":"10.1016\/j.nano.2015.07.010_bb0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-12-385493-3.00004-8","article-title":"Apoptosis and beyond: cytometry in studies of programmed cell death","volume":"103","author":"Wlodkowic","year":"2011","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.nano.2015.07.010_bb0180","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ctrv.2008.07.004","article-title":"Elevated copper and oxidative stress in cancer cells as a target for cancer treatment","volume":"35","author":"Gupte","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.nano.2015.07.010_bb0185","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2015.07.010_bb0190","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat Rev Drug Discov"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415001537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415001537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T02:25:24Z","timestamp":1537410324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963415001537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1549963415001537"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2015.07.010","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2015.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}